Eradication of HIV by transplantation of CCR5-deficient hematopoietic stem cells

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1068-1076

  Hütter, Gero ^a,b   Ganepola, Susanne ^c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b German Red Cross Blood Service Baden Württemberg Hessen   (Germany)

^c ASKLEPIOS KLINIK ALTONA   (Germany)

Author keywords

Allogeneic stem cells; CCR5; CCR5 delta32; HIV; Transplantation

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN A; CYTARABINE; GEMTUZUMAB; MARAVIROC; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; VIRUS DNA;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; BLOOD CELL; BRAIN TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE; LIVER; LYMPHOID CELL; NOTE; TISSUE SECTION; VIRUS LOAD;

COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; LEUKEMIA, MYELOID, ACUTE; RECEPTORS, CCR5; RNA, VIRAL; SEQUENCE DELETION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79958125260     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.102     Document Type: Note

References (30)

1. Lederman, M.M., Penn-Nicholson, A., Cho, M., and Mosier, D. (2006) Biology of CCR5 and its role in HIV infection and treatment. JAMA 296, 815-826. (Pubitemid 44223105)
2. Liu, R., Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R., Horuk, R., MacDonald, M.E., Stuhlmann, H., Koup, R.A., and Landau, N.R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377. (Pubitemid 26272077)
3. Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard, C., Farber, C.M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G., and Parmentier, M. (1996) Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722-725.
4. Rosen, O., Sharon, M., Quadt-Akabayov, S.R., and Anglister, J. (2006) Molecular switch for alternative conformations of the HIV-1 V3 region: implications for phenotype conversion. Proc. Natl. Acad. Sci. U. S. A. 103, 13950-13955. (Pubitemid 44452963)
5. Delobel, P., Sandres-Saune, K., Cazabat, M., Pasquier, C., Marchou, B., Massip, P., and Izopet, J. (2005) R5 to X4 switch of the predominant HIV-1 population in cellular reservoirs during effective highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 38, 382-392. (Pubitemid 40381547)
6. Hütter, G. and Zaia, J.A. (2011) Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin. Exp. Immunol. 163, 284-295.
7. Chen, T.K., Moore, T.B., Territo, M., Chow, R., Tonai, R., Petz, I., Rossi, J., Mitsuyasu, R., Rosenthal, J., Forman, S.J., Zaia, J.A., and Bryson, Y.J. (2008) The feasibility of using CCR5D32/D32 hematopoietic stem cell transplants for immunereconstitution in HIV-infected children. Biol. Blood Marrow Transplant. 14, Abstract 324.
8. Perez, E.E., Wang, J., Miller, J.C., Jouvenot, Y., Kim, K.A., Liu, O., Wang, N., Lee, G., Bartsevich, V.V., Lee, Y.L., Guschin, D.Y., Rupniewski, I., Waite, A.J., Carpenito, C., Carroll, R.G., Orange, J.S., Urnov, F.D., Rebar, E.J., Ando, D., Gregory, P.D., Riley, J.L., Holmes, M.C., and June, C.H. (2008) Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol. 26, 808-816. (Pubitemid 351961450)
9. Hütter, G., Nowak, D., Mossner, M., Ganepola, S., Mussig, A., Allers, K., Schneider, T., Hofmann, J., Kucherer, C., Blau, O., Blau, I.W., Hofmann, W.K., and Thiel, E. (2009) Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 360, 692-698.
10. Allers, K., Hütter, G., Hofmann, J., Loddenkemper, C., Rieger, K., Thiel, E., and Schneider, T. (2011) Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation. Blood 117, 2791-2799.
11. Archer, J., Rambaut, A., Taillon, B.E., Harrigan, P.R., Lewis, M., and Robertson, D.L. (2010) The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time - an ultra-deep approach. PLoS Comput. Biol. 6, e1001022.
12. Moore, J.P., Kitchen, S.G., Pugach, P., and Zack, J.A. (2004) The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 20, 111-126. (Pubitemid 38147183)
13. Kinter, A., Arthos, J., Cicala, C., and Fauci, A.S. (2000) Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis. Immunol. Rev. 177, 88-98.
14. Poropatich, K. and Sullivan, D.J., Jr. Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression. J. Gen. Virol. 92(Pt 2), 247-268.
15. Carrington, M., Martin, M.P., and van Bergen, J. (2008) KIR-HLA intercourse in HIV disease. Trends Microbiol. 16, 620-627.
16. Kaslow, R.A., Carrington, M., Apple, R., Park, L., Munoz, A., Saah, A.J., Goedert, J.J., Winkler, C., O'Brien, S.J., Rinaldo, C., Detels, R., Blattner, W., Phair, J., Erlich, H., and Mann, D.L. (1996) Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2, 405-411. (Pubitemid 26193012)
17. Avettand-Fenoel, V., Prazuck, T., Hocqueloux, L., Melard, A., Michau, C., Kerdraon, R., Agoute, E., and Rouzioux, C. (2008) HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors. AIDS 22, 1880-1882.
18. Carter, J.T., Melcher, M.L., Carlson, L.L., Roland, M.E., and Stock, P.G. (2006) Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am. J. Transplant. 6, 753-760. (Pubitemid 43345013)
19. Rizzardi, G.P., Harari, A., Capiluppi, B., Tambussi, G., Ellefsen, K., Ciuffreda, D., Champagne, P., Bart, P.A., Chave, J.P., Lazzarin, A., and Pantaleo, G. (2002) Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J. Clin. Invest. 109, 681-688. (Pubitemid 34204847)
20. Sorgel, F. (2004) The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts? Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday. Chemotherapy 50, 6-10.
21. Simard, A.R. and Rivest, S. (2004) Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18, 998-1000. (Pubitemid 39561504)
22. Davey, R.T., Jr., Bhat, N., Yoder, C., Chun, T.W., Metcalf, J.A., Dewar, R., Natarajan, V., Lempicki, R.A., Adelsberger, J.W., Miller, K.D., Kovacs, J.A., Polis, M.A., Walker, R.E., Falloon, J., Masur, H., Gee, D., Baseler, M., Dimitrov, D.S., Fauci, A.S., and Lane, H.C. (1999) HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. U. S. A. 96, 15109-15114. (Pubitemid 30019773)
23. Chun, T.W., Justement, J.S., Murray, D., Hallahan, C.W., Maenza, J., Collier, A.C., Sheth, P.M., Kaul, R., Ostrowski, M., Moir, S., Kovacs, C., and Fauci, A.S. (2010) Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS 24, 2803-2808.
24. Gooley, T.A., Chien, J.W., Pergam, S.A., Hingorani, S., Sorror, M.L., Boeckh, M., Martin, P.J., Sandmaier, B.M., Marr, K.A., Appelbaum, F.R., Storb, R., and McDonald, G.B. (2010) Reduced mortality after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 363, 2091-2101.
25. Sewell, A.K., Price, D.A., Oxenius, A., Kelleher, A.D., and Phillips, R.E. (2000) Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape. Stem Cells 18, 230-244. (Pubitemid 30602270)
26. Woolfrey, A.E., Malhotra, U., Harrington, R.D., McNevin, J., Manley, T.J., Riddell, S.R., Coombs, R.W., Appelbaum, F.R., Corey, L., and Storb, R. (2008) Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation. Blood 112, 3484-3487.
27. Hütter, G. and Thiel, E. (2010) Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2. AIDS 25, 273-274.
28. Cohn, S.K., Jr. and Weaver, L.T. (2006) The Black Death and AIDS: CCR5-Delta32 in genetics and history. QJM 99, 497-503.
29. Gonzalez, G., Park, S., Chen, D., Armitage, S., Shpall, E., and Behringer, R. (2011) Identification and frequency of CCR5Delta32/Delta32 HIV-resistant cord blood units from Houston area hospitals. HIV Med. [Epub ahead of print]
30. Hütter, G., Schneider, T., and Thiel, E. (2009) Transplantation of selected or transgenic blood stem cells - a future treatment for HIV/AIDS? J. Int. AIDS Soc. 12, 10.